IRON Live signals | Maximize Profits with Getagraph.com

BUY 100047 min ago

@ $67.84

Issued: 14 Feb 2024 @ 13:50

Return: -60.20%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: 0.52 %

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 16:00):

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases...

Stats
Today's Volume	544 173
Average Volume	450 461
Market Cap	666.39M
EPS	$0 ( 2024-03-29 )
Next earnings date	( $-1.000 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.89
ATR14	$0.0530 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-11	White William Richard	Sell	1 756	Stock Option (Right to Buy)
2024-04-11	White William Richard	Sell	804	Stock Option (Right to Buy)
2024-04-11	White William Richard	Buy	804	Common Stock
2024-04-11	White William Richard	Buy	1 756	Common Stock
2024-04-11	White William Richard	Sell	2 482	Common Stock

INSIDER POWER
42.43
Last 63 transactions
Buy: 3 902 814 \| Sell: 904 810

Volume Correlation

Long: -0.50 (neutral)

Short: -0.55 (weak negative)

Signal:(24.793) Neutral

Disc Medicine, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Disc Medicine, Inc. Correlation - Currency/Commodity

0.35
( neutral )

0.56
( weak )

0.00
( neutral )

0.25
( neutral )

0.32
( neutral )

0.35
( neutral )

Disc Medicine, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-3.42

Q4	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.980

Q3	2023
Revenue:	$0
Gross Profit:	$-25 000.00 (0.00 %)
EPS:	$-0.580

Q2	2023
Revenue:	$0
Gross Profit:	$-75 000.00 (0.00 %)
EPS:	$-0.740

Financial Reports:

No articles found.

Disc Medicine, Inc.

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.